
Orchestra Biomed Holdings Hits New 52-Week Low at $2.20
2025-09-25 16:53:41Orchestra Biomed Holdings, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant decline in stock price. The company operates at a loss, with concerning financial metrics, including negative return on equity and operating cash flow, while consistently underperforming against the S&P 500.
Read More
Orchestra Biomed Holdings Hits New 52-Week Low at $2.33
2025-09-24 13:44:01Orchestra Biomed Holdings, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant decline in performance. The company faces substantial financial hurdles, including a notable operating cash flow loss and negative EBITDA, alongside concerning financial metrics that impact market sentiment.
Read MoreIs Orchestra Biomed Holdings, Inc. technically bullish or bearish?
2025-09-20 20:26:37As of 11 September 2025, the technical trend for Orchestra Biomed Holdings, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength, indicated by the daily moving averages being bearish and the monthly MACD also showing a bearish signal. The Bollinger Bands are bearish on both weekly and monthly time frames, further supporting this bearish outlook. The KST and OBV show mildly bearish signals on the weekly, but are bearish on the monthly for KST. In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -37.25% versus the S&P 500's 12.22%, and a one-year return of -48.67% compared to 17.14% for the index....
Read More





